AUTHORS: Bonnet, Marie-Pierre MD, PhD et al Anesthesia & Analgesia: January 2018 – Volume 126 – Issue 1 – p 175–182 BACKGROUND: A structured definition of amniotic fluid embolism (AFE) based on 4 criteria was recently proposed for use in research by the Society for Maternal-Fetal Medicine (SMFM) and the Amniotic Fluid Embolism Foundation. The main objective […]
Read MoreThis is for our readers who perform chronic pain management. In 2 articles published in the Journal of the National Cancer Institute researchers have found that peripheral neuropathy can bother patients with early-stage breast cancer years after completing chemotherapy. In addition, a systematic literature review found that only a handful of studies actually tracked long-term peripheral neuropathy, […]
Read MoreMonitoring and intervention strategies for patients with respiratory compromise are much more efficient and effective if patients are first categorized by the type of respiratory condition they have. This contrasts with the mentality of monitoring by putting all respiratory patients into the same bucket. This assessment was made following a workshop organized by the National […]
Read MoreAUTHORS: Foley, Amanda MD et al Anesthesia & Analgesia: March 2018 – Volume 126 – Issue 3 – p 920–924 BACKGROUND: Experts recommend postpartum oxytocin to prevent uterine atony and hemorrhage, but oxytocin may be associated with dose-dependent adverse effects, and the correct dose of postpartum oxytocin has yet to be determined. The effective dose in 90% […]
Read MoreAUTHORS: Gelineau, Amanda M. MD et al Anesthesia & Analgesia: March 2018 – Volume 126 – Issue 3 – p 1035–1049 BACKGROUND: Esmolol is an ultrashort β-1 receptor antagonist. Recent studies suggest a role for esmolol in pain response modulation. The authors performed a meta-analysis to determine if the intraoperative use of esmolol reduces opioid consumption or […]
Read More